ConductScience.org, home

Gene · 1725

Papers1,523

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Bactericidal Activity of Eugenol-Rich Syzygium aromaticum Essential Oil Against Multidrug-Resistant Bacteria Isolated from Commercial Eggs.Pathogens202642796678PubTator, text miningPubMed
The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability.Biochim Biophys Acta Rev Cancer202642604705PubTator, text miningPubMed
Effect of sulphadoxine-pyrimethamine resistance on birthweight and parasite persistence among women receiving intermittent preventive treatment for malaria in pregnancy in Northern Uganda: a directed acyclic graph-guided analysis.
Clin Microbiol Infect202642595091PubTator, text miningPubMed
Protocol for proteomic profiling of hypusinated protein candidates using a clickable spermidine probe.STAR Protoc202642574220PubTator, text miningPubMed
Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy.Hum Cell202642469533PubTator, text miningPubMed
Metabolomics reveals potentiated metabolic perturbations induced by antimalarial drug combinations against Plasmodium falciparum in vitro.Exp Parasitol202642468680PubTator, text miningPubMed
Design, synthesis, biological assessment, and integrated computational analysis of new pyrazole-based antimicrobial candidates.Sci Rep202642432042PubTator, text miningPubMed
Drug resistance gene polymorphisms of Plasmodium falciparum clinical isolates from Kinshasa, Democratic Republic of the Congo.Trop Med Health202642415199PubTator, text miningPubMed
Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease.Arterioscler Thromb Vasc Biol202642389790PubTator, text miningPubMed
Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021-2023.Front Genet202642311757PubTator, text miningPubMed
Regulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness.Cancer Lett202642297232PubTator, text miningPubMed
Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024.Antimicrob Agents Chemother202642294652PubTator, text miningPubMed
A gene therapy strategy for Deoxyhypusine Synthase (DHPS) syndrome.Res Sq202642239796PubTator, text miningPubMed
Geographical Variation in Antimalarial Drug Resistance Marker Prevalence Across the Southern African Elimination Eight Region.medRxiv202642238473PubTator, text miningPubMed
Schiff base chromones from natural Benzofuran as potential scaffold for anti-Staphylococcus aureus: synthesis of cis and trans isomers, in vitro and in silico studies.Nat Prod Res202642172131PubTator, text miningPubMed
Concurrent pulmonary, hepatic and cerebral pneumocystosis: case report and review of the literature.BMC Infect Dis202642168888PubTator, text miningPubMed
Polyamine Metabolism and the DHPS/eIF5A Hypusination Axis: From Metabolic Reprogramming to a Therapeutic Achilles' Heel in Melanoma.Biomolecules202642072695PubTator, text miningPubMed
Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024.Emerg Infect Dis202641927306PubTator, text miningPubMed
Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24.medRxiv202641891011PubTator, text miningPubMed
Modeling the Impact of Malaria Chemoprevention with sulphadoxine-pyrimethamine on the spread of Plasmodium falciparum dhps A581G mutation.Infect Dis Model202641889445PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1725/papers